Status:
COMPLETED
AF Coronary Embolism Long Term Outcomes
Lead Sponsor:
Fundacion Miguel Servet
Conditions:
Coronary Embolism
Atrial Fibrillation (AF)
Eligibility:
All Genders
18+ years
Brief Summary
Introduction Coronary embolism (CE) is a relatively rare but significant cause of non-atherosclerotic acute myocardial infarction (AMI), representing about 3% of all AMI cases, though it is likely und...
Detailed Description
INTRODUCTION Coronary embolism (CE) represents a distinct and under-recognized cause of acute myocardial infarction (AMI) that does not involve atherosclerotic processes. Despite its relatively low r...
Eligibility Criteria
Inclusion
- Consecutive patients admitted to a specialized cardiology care facility were retrospectively reviewed for inclusion in the study. Eligibility was contingent upon two primary criteria: fulfillment of the Fourth Universal Definition of AMI and classification as definite or probable CE according to the diagnostic framework proposed by Shibata et al. Patients satisfying these combined diagnostic benchmarks were incorporated into the final study cohort.
Exclusion
- Patients exhibiting angiographic or intracoronary imaging evidence of atherosclerotic thrombus, previous percutaneous coronary intervention or bypass grafting, coronary artery ectasia, plaque rupture or erosion, spontaneous coronary artery dissection, or coronary vasospasm were excluded. Likewise, patients with stress-induced cardiomyopathy were also excluded
Key Trial Info
Start Date :
April 1 2024
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 19 2025
Estimated Enrollment :
400 Patients enrolled
Trial Details
Trial ID
NCT06948240
Start Date
April 1 2024
End Date
April 19 2025
Last Update
April 29 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital Universitario de Navarra
Pamplona, Navarre, Spain, 31008